Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines. The Company uses several approaches to intervene at strategic points throughout the autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens and to arrest or reverse the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders, and neurodegeneration, among other indications.
|HQ||Cambridge, MA, US||Map|
|Employees (est.) (Nov 2021)||51||(+2%)|
Casma Therapeutics total Funding
Casma Therapeutics latest funding size
Time since last funding
|a year ago|
Casma Therapeutics investors
|The Column Group, Third Rock Ventures, Schroder Adveq, Eventide Asset Management|
Casma Therapeutics has 386 Twitter Followers. The number of followers has increased 1.8% month over month and increased 17.1% quarter over quarter
When was Casma Therapeutics founded?
Casma Therapeutics was founded in 2018.
Who are Casma Therapeutics key executives?
Casma Therapeutics's key executives are Keith Dionne, Frank Gentile and Leon Murphy.
How many employees does Casma Therapeutics have?
Casma Therapeutics has 51 employees.
Who are Casma Therapeutics competitors?
Competitors of Casma Therapeutics include Discovery Biomed, AOBiome and Asterion.
Where is Casma Therapeutics headquarters?
Casma Therapeutics headquarters is located at 400 Technology Square, Cambridge.
Where are Casma Therapeutics offices?
Casma Therapeutics has an office in Cambridge.
How many offices does Casma Therapeutics have?
Casma Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies